Role of vitamin D in anti-infective immunity

Rudyk A.V.

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Welfare, Moscow
The literature data on the osseous and extraosseous effects of vitamin D, its pleiotropic mechanism of involvement in metabolic processes are analyzed. The paper reviews studies confirming the extraosseous (pleiotropic) effect of vitamin D and describes the pathogenetic ways of realizing the above effects. The anti-inflammatory and immunomodulatory properties of vitamin D as a factor of nonspecific protection in infections of various genesis (viral and bacterial) allow it to be used for the prevention and treatment of tuberculosis, hepatitis C, influenza A, acute respiratory infections, chronic rhinosinusitis, and pneumonia. A relationship of vitamin D to cardiovascular and kidney diseases, immune and nervous system disorders, and aging is considered in terms of the data of current studies. There are data on vitamin D provision in the pediatric population of the Russian Federation and on the normal serum levels of the active vitamin D metabolite 25(OH)D; a stepwise dosage regimen of vitamin D as cholecalciferol for prevention is given. Further studies in this area will be able to reconsider approaches to the therapy of infectious diseases and their prevention from birth to adulthood, by applying the physiological mechanisms of immune regulation.


1. Zaplatnikov A.L., Korovina N.A. [Often ill children: current state of the problem]. Voprosy prakticheskoj pediatrii 2008; 3(5): 103–9. (In Russ.)

2. Yarcev M.N., Plahtienko M.V. [Frequently ill children and immune deficiency]. Rossijskij allergologicheskij zhurnal 2010; (5): 58–66. (In Russ.)

3. Novikov P.V. [Rickets and hereditary rickets disease in children]. Moscow: Triada-Х, 2006; 24–43. (In Russ.)

4. Bischoff-Ferrari H.A., Burckhardt P., Quack-Loetscher K., Gerber B., I’Allemand D., Laimbacher J., Bachmann M., Rizzoli R. Vitamin D deficiency: Evidence, safety, and recommendations for the Swiss population. Report written by a group of experts on behalf of the Federal Commission for Nutrition (FCN) 2012. http://www.

5. Armbrecht H.J., Forte L.R., Halloran P.B. Effect of age and dietary calcium on renal 25(OH)D metabolism, serum 1,25(OH)2D, and PTH. Am. J. Physiol. 1984; 246(3): 266–70.

6. Shin J.S., Choi M.Y., Longtin M.S., Nelson D.M. [Effect vitamin D in pregnancy and placenta]. Placenta 2010; (8): 1–8.

7. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., Ochoa M.T., Schauber J., Wu K., Meinken C., Kamen D.L., Wagner M., Bals R., Steinmeyer A., Zugel U., Gallo R.L., Eisenberg D., Hewison M., Hollis B.W., Adams J.S., Bloom B.R., Modlin R.L. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311(5768): 1770–3.

8. Liu P.T. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependen on the induction of cathelicidin. J. Immunol. 2007; 179(4): 2060–63.

9. Jeng L., Yamshchikov A.V., Judd S.E., Blumberg H.M., Martin G.S., Ziegler T.R., Tangpricha V. Alterations in vitamin D status and antimicrobialpeptide levels in patients in the intensive care unit with sepsis. J. Transl. Med. 2009; (7): 28. DOI: 10.1186/1479-5876-7-28.

10. Tian-Tian Wang, Frederick P. Nestel, Véronique Bourdeau, Yoshihiko Nagai, Qiuyu Wang, Jie Liao, Luz Tavera-Mendoza, Roberto Lin, John H. Hanrahan, Sylvie Mader and John H. White. Cutting Edge: 1,25-OH D3 Is a Direct Inducer of Antimicrobial Peptid Gene Expression. Immunology 2004; 173(5): 2909–12.

11. Urashima M., Segawa T., Okazaki M., Kurihara M., Wada Y., Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am. J. Clin. Nutr. 2010; 91(5): 1255–60. DOI: 10.3945/ajcn.2009.29094.

12. Camargo C.A., Davaasambuu Ganmaa, Frazier A.L., Kirchberg F.F., Stuart J. J., Kleinman K., Sumberzul N., Rich-Edwards J.W. Randomized Trial of Vitamin D Supplementation and Risk of Acute Respiratory Infection in Mongolia. Pediatrics 2012; 130(3): 561–7.

13. Manaseki-Holland S., Qader G., Masher I.M., Bruce J., Zulf Mughal M., Chandramohan D., Walraven G. Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomised controlled trial. Trop. Med. Int. Health. 2010; 15(10): 1148–55.

14. Rook G.A. The rol of vitamin D in tuberculosis. Am. Rev. Respir. Dis. 1988; 138(4): 768–70.

15. Davies P.D. A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis. Tubercle 1985; 66(4): 301–6.

16. Martineau A.R. Old wine in new bottles: vitamin D in the treatment and prevention of tuberculosis. Proc. Nutr. Soc. 2012; 71(1): 84–9.

17. Selvaraj P. Vitamin D, vitamin D receptor, and cathelicidini in the treatment of tuberculosis. Vitam Horm. 2011; 86: 307–25.

18. Salahuddin N., Ali F., Hasan Z., Rao N., Aqeel M., Mahmood F. Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’. BMC Infect. Dis. 2013; 13: 22. DOI: 10.1186/1471-2334-13-22 .

19. Yosef H. Saeed Abdelkarim, Agila Al-Barasi, Essam S. Hussien, Effect of Vitamin-D Supplement in Patients Diagnosed as Chronic Rhinosinusitis with Vitamin-D Deficiency. International Journal of Otorhinolaryngology 2016; 2(1): 1–4.

20. Bitetto D., Fabris C. Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C. Transpl. Int. 2011; 24(1): 43–50.

21. Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007; 357(3): 266–81.

22. Thandrayen K., Pettifor J.M. Maternal Vitamin implications for the development of infantile nutritional rickets. Endocrinology and Metabolism. Clinics of North America. 2010; 39(2): 303–20.

23. Autier P., Gandini S. Vitamin D supplementation and total mortality: A metaanalysis of randomized controlled trials. Arсh. Intern. Med. 2007; 167(16): 1730–7.

24. Zaharova I.N., Mal’cev S.V., Borovik G.V., Yacyk T.Ye., Malyavskaya S.I., Vaxlova I.V., Shumatova T.A., Romancova E.B., Romanyuk F.P., Klimov L.Ya., Elkina T.N., Pirozhkova N.I., Kolesnikova S.M., Kur’yaninova V.A., Vasil’eva S.V., Mozzhuxina M.V., Evseeva E.A. [Results of a multicenter study ≪RODNICHOK≫ for the study of vitamin D deficiency in children of early age in Russia]. .Pediatriуa. Zhurnal imеni G.N. Speranskogo 2015; (1): 62–70. (In Russ.)

25. Institute of Medicine (US). Committee to Review Dietary Reference Intakes for Calcium and Vitamin D. Ross A.C., Taylor C.L., Yaktine A.L., Del Valle H. (eds.). Washington (DC): National Academies Press (US), 2011.

26. Gromova O.A., Torshin I.Yu., Zaharova I.N., SpirichevV.B., Lanova O.A., Borovik T.Je., Yacyk G.V.. [About dosing vitamin D in children and adolescents]. Voprosy sovremennoj pediatrii 2015; 14(1): 38–47. DOI: (In Russ.).

27. Zaharova I.N., Tvorogova T.M., Vecherko V.I., Lazareva S.I., Vasil’eva S.V., Evseeva E.A. [Monitoring of vitamin D status in adolescents of the city of Moscow in the course of the year]. Pediatriуа 2015; 93(3): 114–20. (In Russ.)

About the Autors

For correspondence: Anna V. Rudyk,

Similar Articles

Бионика Медиа